Keywords: درمان غدد درون ریز; Endocrine therapy; breast cancer; aromatase inhibitors; tamoxifen
مقالات ISI درمان غدد درون ریز (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Endocrine therapy and palbociclib within a compassionate use program in heavily pretreated hormone receptor-positive, HER2-negative metastatic breast cancer
Keywords: درمان غدد درون ریز; Hormone receptor-positive metastatic breast cancer; Endocrine therapy; Endocrine resistant; Palbociclib; Heavily pretreated;
Omitting radiotherapy in women ⥠65 years with low-risk early breast cancer after breast-conserving surgery and adjuvant endocrine therapy is safe
Keywords: درمان غدد درون ریز; Breast-conserving surgery; Endocrine therapy; Postoperative radiotherapy;
Combined effects of neoadjuvant letrozole and zoledronic acid on γδT cells in postmenopausal women with early-stage breast cancer
Keywords: درمان غدد درون ریز; Zoledronic acid; γδ T cell; Breast cancer; Neoadjuvant; Endocrine therapy;
Adherence to Adjuvant Endocrine Therapy in Christchurch Women with Early Breast Cancer
Keywords: درمان غدد درون ریز; Adjuvant therapy; breast cancer; early stage; endocrine therapy; patient adherence;
Fulvestrant plus goserelin versus anastrozole plus goserelin versus goserelin alone for hormone receptor-positive, HER2-negative tamoxifen-pretreated premenopausal women with recurrent or metastatic breast cancer (KCSG BR10-04): a multicentre, open-label,
Keywords: درمان غدد درون ریز; Metastatic breast cancer; Premenopausal; Fulvestrant; Endocrine therapy;
Ovarian suppression failure during GnRH agonist treatment: A report of three breast cancer patients
Keywords: درمان غدد درون ریز; AI; aromatase inhibitor; E2; estradiol; GA; GnRH agonist; GnRH; gonadotropin-releasing hormone; IM; intramuscularly; NST; no special type; SC; subcutaneously; Endocrine therapy; Ovarian suppression; GnRH agonist; Breast cancer; Estradiol; Premenopausal;
Progression-free Survival With First-line Endocrine-based Therapies Among Postmenopausal Women With HR+/HER2- Metastatic Breast Cancer:
Keywords: درمان غدد درون ریز; endocrine therapy; HR positive/HER2 negative; metastatic breast cancer; network meta-analysis; progression-free survival; targeted therapy;
Everolimus Plus Letrozole for Treatment of Patients With HR+, HER2- Advanced Breast Cancer Progressing on Endocrine Therapy: An Open-label, Phase II Trial
Keywords: درمان غدد درون ریز; Advanced breast cancer; Endocrine therapy; Everolimus; Hormone receptor-positive; Letrozole;
Emerging aspects of microRNA interaction with TMPRSS2-ERG and endocrine therapy
Keywords: درمان غدد درون ریز; microRNAs; TMPRSS2-ERG; GR; Endocrine therapy; Prostate cancer;
Initiation of Adjuvant Endocrine Therapy in Black and White Women With Breast Cancer
Keywords: درمان غدد درون ریز; Black women; Breast cancer; Endocrine therapy; White women;
Everolimus-based combination therapies for HR+, HER2â metastatic breast cancer
Keywords: درمان غدد درون ریز; Everolimus; Metastatic breast cancer; Endocrine therapy; Hormone receptor-positive;
Optimal sequence of adjuvant endocrine and radiation therapy in early-stage breast cancer - A systematic review
Keywords: درمان غدد درون ریز; Breast cancer; Adjuvant therapy; Radiotherapy; Endocrine therapy;
Neoadjuvant endocrine therapy in breast cancer patients
Keywords: درمان غدد درون ریز; Breast cancer; Neoadjuvant treatment; Endocrine therapy; Estrogen receptor-positive; Breast conserving surgery;
Treatment with aromatase inhibitors stimulates the expression of epidermal growth factor receptor-1 and neuregulin 1 in ER positive/HER-2/neu non-amplified primary breast cancers
Keywords: درمان غدد درون ریز; ErbB; Neuregulin-1; Endocrine therapy; Breast cancer;
Original ResearchImproved survival for patients with de novo metastatic prostate cancer in the last 20 years
Keywords: درمان غدد درون ریز; Prostate cancer; Metastatic prostate cancer; Endocrine therapy; Overall survival; Cancer-specific survival; Relative survival;
Palliative systemic therapy and overall survival of 1,395 patients with advanced breast cancer - Results from the prospective German TMK cohort study
Keywords: درمان غدد درون ریز; Breast neoplasms; Cohort studies; Palliative care; Outpatients; Real-world data; Registries; ABC; advanced breast cancer; AGO; Arbeitsgemeinschaft Gynäkologische Onkologie; Bev; bevacizumab; C; cyclophosphamid; Cap; capecitabine; Car; carboplatin; CCI; C
Patient database analysis of fulvestrant 500Â mg in the treatment of metastatic breast cancer: A European perspective
Keywords: درمان غدد درون ریز; Hormone receptor-positive breast cancer; Endocrine therapy; Chemotherapy; Guidelines; Treatment patterns; Quality of care;
Neoadjuvant Therapy in Early Breast Cancer: Treatment Considerations and Common Debates in Practice
Keywords: درمان غدد درون ریز; Breast cancer; chemotherapy; endocrine therapy; multidisciplinary; neoadjuvant treatment; patient management;
The next era of treatment for hormone receptor-positive, HER2-negative advanced breast cancer: Triplet combination-based endocrine therapies
Keywords: درمان غدد درون ریز; Advanced breast cancer; Cyclin-dependent kinase 4/6 inhibitor; Endocrine therapy; Hormone receptor-positive; PI3K/mTOR inhibitor;
Daily Practice Management of pT1a-b pN0 Breast Carcinoma: A Prospective French ODISSEE Cohort Study
Keywords: درمان غدد درون ریز; Adjuvant treatment; Breast cancer subtypes; Conservative surgery; Endocrine therapy; Radiotherapy;
Circulating oxysterol metabolites as potential new surrogate markers in patients with hormone receptor-positive breast cancer: Results of the OXYTAM study
Keywords: درمان غدد درون ریز; BC; breast cancer; Tam; tamoxifen; AEBS; antiestrogen binding site; ET; endocrine therapy; OS; oxysterol; AI; aromatase inhibitors; 24-HC; 24-hydroxycholesterol; 25-HC; 25-hydroxycholesterol; 27-HC; 27-hydroxycholesterol; 7α-HC; 7α-hydroxycholesterol; 7
Are SOFT and TEXT results practice changing and how?
Keywords: درمان غدد درون ریز; Premenopausal; Breast cancer; Endocrine therapy; Exemestane; Ovarian suppression; Tamoxifen;
Endocrine therapy for hormone treatment-naïve advanced breast cancer
Keywords: درمان غدد درون ریز; Advanced breast cancer; Metastatic breast cancer; Endocrine therapy; Endocrine therapy-naïve; CBR; clinical benefit rate; CDK; cyclin-dependent kinase; CI; confidence interval; ER; estrogen receptor; HER; human epidermal growth factor receptor; HR; hazar
Current and emerging therapies of HER2-positive metastatic breast cancer
Keywords: درمان غدد درون ریز; Breast cancer; Metastatic; HER2; Biomarkers; Targeted therapy; Endocrine therapy;
Nouvelles options en hormonothérapie adjuvante des cancers du sein
Keywords: درمان غدد درون ریز; Cancer du sein; Hormonothérapie; Adjuvant; Breast cancer; Endocrine therapy; Adjuvant therapy;
Prognostic Value of a BCSC-associated MicroRNA Signature in Hormone Receptor-Positive HER2-Negative Breast Cancer
Keywords: درمان غدد درون ریز; BCSCs; Breast cancer stem cells; miRNAs; MicroRNAs; DRFS; Distant relapse free survival; IHC; Immunohistochemistry; ER; Estrogen receptor; HR; Hormone receptor; CSCs; Cancer stem cells; RS; Recurrence score; FFPE; Formalin-fixed paraffin-embedded; SYSMH;
Use of implicit persuasion in decision making about adjuvant cancer treatment: A potential barrier to shared decision making
Keywords: درمان غدد درون ریز; Implicit persuasion; Shared decision making; Breast cancer; Chemotherapy; Endocrine therapy;
Effectiveness of Everolimus Versus Endocrine Monotherapy or Chemotherapy Among HR+/HER2â mBC Patients With Multiple Metastatic Sites
Keywords: درمان غدد درون ریز; chemotherapy; clinical outcome; endocrine therapy; everolimus; HR+/HER2â metastatic breast cancer;
Unravelling exemestane: From biology to clinical prospects
Keywords: درمان غدد درون ریز; AI(s); aromatase inhibitor (s); AKT; protein kinase B; AREG; amphiregulin; BMD; bone mineral density; CYP; cytochrome P450; DHEAS; dehydroepiandrosterone sulfate; EGF; epidermal growth factor; EGFR; epidermal growth factor receptor; EMA; European Medicine
KLF17 attenuates estrogen receptor α-mediated signaling by impeding ERα function on chromatin and determines response to endocrine therapy
Keywords: درمان غدد درون ریز; Estrogen receptor α; KLF17; Breast cancer; Endocrine therapy; HDAC1; p300;
Insights into biology of luminal HER2 vs. enriched HER2 subtypes: Therapeutic implications
Keywords: درمان غدد درون ریز; Early breast cancer; Endocrine therapy; HER2-positive; Pertuzumab; T-DM1; Trastuzumab;
Long term effects of extended adjuvant endocrine therapy on quality of life in breast cancer patients
Keywords: درمان غدد درون ریز; Breast cancer; Endocrine therapy; Quality of life; Extended adjuvant therapy;
Adherence to adjuvant endocrine therapy: Is it a factor for ethnic differences in breast cancer outcomes in New Zealand?
Keywords: درمان غدد درون ریز; Breast cancer; Endocrine therapy; Medication adherence; Ethnicity; Inequity
Glyceollin, a novel regulator of mTOR/p70S6 in estrogen receptor positive breast cancer
Keywords: درمان غدد درون ریز; Glyceollin; Endocrine therapy; p70S6; Estrogen receptor (ER); mTOR; Anti-estrogen; Kinase signaling;
Neoadjuvant endocrine therapy for resectable breast cancer: AÂ systematic review and meta-analysis
Keywords: درمان غدد درون ریز; Endocrine therapy; Breast cancer; Neoadjuvant; Preoperative; Tamoxifen; Aromatase inhibitor;
Medication taking behaviors among breast cancer patients on adjuvant endocrine therapy
Keywords: درمان غدد درون ریز; Breast cancer; Endocrine therapy; Adherence; Self-efficacy;
Fulvestrant with or without selumetinib, a MEK 1/2 inhibitor, in breast cancer progressing after aromatase inhibitor therapy: A multicentre randomised placebo-controlled double-blind phase II trial, SAKK 21/08
Keywords: درمان غدد درون ریز; Advanced breast cancer; Fulvestrant; Selumetinib; Endocrine therapy; MEK 1/2 inhibitor; MAPK pathway;
A new era of improving progression-free survival with dual blockade in postmenopausal HR+, HER2â advanced breast cancer
Keywords: درمان غدد درون ریز; Endocrine therapy; Everolimus; Hormone receptor-positive advanced breast cancer; mTOR inhibitor; Overall survival; Progression-free survival;
Recent advances in the treatment of hormone receptor positive HER2 negative metastatic breast cancer
Keywords: درمان غدد درون ریز; Targeted agents; Metastatic breast cancer; Endocrine therapy; Endocrine resistance; Next generation sequencing technologies
The estrogen receptor alpha nuclear localization sequence is critical for fulvestrant-induced degradation of the receptor
Keywords: درمان غدد درون ریز; Breast cancer; Degradation; Endocrine therapy; Estrogen receptor; Fulvestrant; Nuclear localization sequenceAF-1, activation function 1; AF-2, activation function 2; ChIP, Chromatin immunoprecipitation; DBD, DNA binding domain; DMSO, Dimethyl sulfoxide; D
Economic Evaluations of Everolimus Versus Other Hormonal Therapies in the Treatment of HR+/HER2â Advanced Breast Cancer From a US Payer Perspective
Keywords: درمان غدد درون ریز; Cost-effectiveness analysis; Endocrine therapy; Markov model; Quality adjusted life year; Targeted therapy;
Laboratory-Clinic InterfaceIs the differentiation into molecular subtypes of breast cancer important for staging, local and systemic therapy, and follow up?
Keywords: درمان غدد درون ریز; AI; aromatase inhibitors; BC; breast cancer; BCS; breast-conserving surgery; BCS; breast cancer survival; CAF; cyclophosphamide, doxorubicin and fluorouracil; CR; complete response; DFS; disease free survival; ER; oestrogen receptor; ET; endocrine therapy
The impact of educational materials on compliance and persistence rates with adjuvant aromatase inhibitor treatment: First-year results from the Compliance of ARomatase Inhibitors AssessmenT In Daily practice through Educational approach (CARIATIDE) study
Keywords: درمان غدد درون ریز; Compliance; Persistence; Adherence; Oncology; Breast cancer; Endocrine therapy;
Neoadjuvant hormonal therapy for endocrine sensitive breast cancer: A systematic review
Keywords: درمان غدد درون ریز; Breast cancer; Neoadjuvant; Surgery; Endocrine therapy; Elderly;
Cushing’s disease: A single centre’s experience using the linear accelerator (LINAC) for stereotactic radiosurgery and fractionated stereotactic radiotherapy
Keywords: درمان غدد درون ریز; Cushing’s disease; Endocrine therapy; Fractionated radiotherapy; Linear accelerator; Post treatment complications; Stereotactic radiosurgery; Tumour control
Targeting the PI3K/AKT/mTOR pathway in estrogen receptor-positive breast cancer
Keywords: درمان غدد درون ریز; Luminal type; Breast cancer; Phosphatidylinositol 3-kinase; PI3K; AKT; Mammalian target of rapamycin; mTOR; Estrogen receptor; Endocrine therapy; Endocrine resistance
Evaluation of the ability of adjuvant tamoxifen-benefit gene signatures to predict outcome of hormone-naive estrogen receptor-positive breast cancer patients treated with tamoxifen in the advanced setting
Keywords: درمان غدد درون ریز; Gene expression; Breast cancer; Endocrine therapy; Tamoxifen; Progression-free survival; DCIS; ductal carcinoma in situ; EMC; Rotterdam Dutch cohort; ER; estrogen receptor; ER+; estrogen receptor-positive; ERBB2; HER2/ERBB2 mRNA level; ESR1; estrogen rece
Drug resistance to targeted therapies: Déjà vu all over again
Keywords: درمان غدد درون ریز; Anticancer therapy; Drug resistance; Targeted therapy; Pathway reactivation; Endocrine therapy; Drug combinationsaCGH, array comparative genomic hybridization; ALK, anaplastic lymphoma kinase; BCAR1, breast cancer anti-estrogen resistance 1; BCR-ABL, brea
Original studyAssociation of Positive EBAG9 Immunoreactivity With Unfavorable Prognosis in Breast Cancer Patients Treated With Tamoxifen
Keywords: درمان غدد درون ریز; EBAG9; Endocrine therapy; Immunohistochemistry; Prognostic factor; Tamoxifen resistance;